Dilavir Injection 5 mg/ml contains Remdesivir, an antiviral medication indicated for the treatment of certain viral infections under hospital supervision. Remdesivir is a nucleotide analog prodrug that works by inhibiting viral RNA-dependent RNA polymerase, an enzyme essential for viral replication. By interfering with viral replication, it helps reduce the viral load and may improve clinical outcomes in appropriately selected patients.

Dilavir Injection is administered intravenously and is intended for use in hospitalized patients where close monitoring is available. It is typically used as part of a comprehensive treatment plan based on current clinical guidelines and physician assessment.

Remdesivir has been widely used in the management of COVID-19 in hospitalized patients requiring supplemental oxygen, as recommended by health authorities and clinical protocols during the pandemic period. Its role is to help shorten recovery time in certain patient populations when administered early in the course of the disease.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Dilavir Injection 5 mg/ml is indicated for:

• Treatment of hospitalized patients with confirmed viral infection where remdesivir therapy is clinically appropriate

• Patients requiring supplemental oxygen but not on invasive mechanical ventilation (as per treatment guidelines)

• Use in adults and pediatric patients (as per approved age and weight criteria)

Therapy should always be initiated and monitored by a qualified healthcare professional in a hospital setting.

Dosage and Administration

Dilavir Injection is administered by intravenous infusion only.

• The typical adult dosing regimen includes a loading dose on the first day followed by a maintenance dose once daily for a specified duration (commonly 5–10 days), depending on clinical response and physician recommendation.

• Pediatric dosing is weight-based and must be determined by a specialist.

The solution should be diluted and infused over the recommended period under aseptic conditions. Renal and hepatic function should be assessed before and during treatment.

Precautions

• Contraindicated in patients with known hypersensitivity to remdesivir or any component of the formulation.

• Liver function tests should be performed before and during therapy.

• Use with caution in patients with impaired renal function.

• Not recommended outside hospital settings.

• Safety in pregnancy and breastfeeding should be evaluated by a physician.

Close monitoring is essential throughout the treatment period.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common adverse reactions may include:

• Nausea

• Elevated liver enzymes

• Headache

• Infusion-related reactions

• Hypersensitivity reactions (rare)

If signs of liver dysfunction or severe allergic reaction occur, treatment should be discontinued immediately.

Storage

Store as directed on the packaging, usually in a controlled environment below the recommended temperature. Protect from light and keep out of reach of children. Follow reconstitution and dilution guidelines carefully.

Dilavir Injection 5 mg/ml provides antiviral support in hospitalized patients when used according to approved medical guidelines and under strict professional supervision.